Beike Biotechnology Receives International Recognition for Quality Control Processes

TAIZHOU, China, April 2 /PRNewswire-Asia/ — Beike Biotechnology Co. Ltd.,
one of the world’s leading biotechnology companies focusing on adult stem cell
therapies, has been awarded ISO9001 certification by the International
Organization for Standardization (“ISO”). This internationally recognized
designation signifies Beike has established a Quality Management System (QMS)
that complies with ISO9001 standards. To be certified to these standards,
Beike’s stem cell preparation laboratory was recently assessed by auditors of
the China Quality Certification Centre (CQC) and joins Beike’s Jiangsu
Province Stem Cell Bank and processing laboratory as the latest Beike facility
to achieve the ISO9001 recognition. The Jiangsu Province Stem Cell Bank and
Regenerative Medicine Base was the first comprehensive storage facility to
receive authentications for both banking and cell processing systems.

Dr. Sean Hu, Chairman and CEO of Beike Biotech, commented, “The
implementation of our comprehensive Quality Management System and its
certification by the China Quality Certification Centre and the International
Organization for Standardization, highlights Beike’s commitment to quality and
safety. To our knowledge, only a small percentage of biotech companies in the
world have established Quality Management Systems conforming to ISO standards
and subsequently obtained certification.”

Since its inception in 2005, Beike has been focused on establishing
rigorous quality control systems and specifications for stem cell
industrialization. Early adoption of the Association of Blood Banks (AABB) and
Foundation for the Accreditation of Cellular Therapy (FACT) standards and
strict attention to quality processes led to the subsequent development of the
firm’s current ISO9001 certified QMS. These extensive preparations and the
commitment of Beike’s senior management through each step of the ISO
certification process substantiate Beike’s dedication to provide safe and
effective stem cell therapies.

“This certification assures our partners performing clinical trials and
the patients receiving our stem cells, that Beike’s stem cell preparation
laboratories and stem cell banks function at the highest worldwide quality
standards,” continued Dr. Hu. “The fact that we are the first comprehensive
stem cell organization in China to achieve this certification reinforces our
relentless quest to deliver the best quality stem cell technologies to the
world.”

Located in China’s Medical City, Beike’s ISO certified stem cell bank is
well positioned for its role as an international leader in life-changing stem
cell technologies. Qian Ling, Director of the Management Committee of China
Medical City, noted, “We are pleased to hear of Beike’s recent ISO9001
accreditation. This is an outstanding achievement. The ISO quality standard is
recognized around the world and will help solidify China Medical City as one
of the primary hubs for stem cell technology research.”

To view the certification documents please go to
http://tinyurl.com/BeikeCertificates .

About Beike Biotechnology Company Limited

Beike Biotechnology (http://www.beikebiotech.com ) is China’s leading
biotechnology company focusing on adult stem cell therapies. Beike’s
scientists have been focused on the development and commercialization of adult
stem cell therapies since 1999. The company currently produces a full line of
stem cell products from umbilical cord, cord blood, and bone marrow stem cells.
Beike’s stem cell therapies are administered by physicians at many leading
hospitals throughout China.

Beike’s unique processing technologies prepare the cells for use in
treating a variety of serious medical conditions including ataxia, brain
injury, cerebral palsy, diabetic foot disease, lower limb ischemia, multiple
sclerosis, muscular dystrophy, spinal cord injury and optic nerve pathologies.

About China Medical City

Located on a 25-square kilometer site in the heart of Taizhou City in
China’s Jiangsu Province, China Medical City was established by the Chinese
Government in 2005 and has active support from the local government. It
represents China’s goal of streamlining the pharmaceutical and medical
materials industry by concentrating all medical services and support in one
central location. The city of Taizhou is fast becoming Jiangsu’s leading
biotech location, with over 35% annual growth since 2004. Jiangsu Province is
home to the largest concentration of China’s medical industry, based on the
revenue generated over the past five years.

About The International Organization for Standardization

The International Organization for Standardization (ISO)
(https://www.iso.org ) is the world’s largest developer and publisher of
International Standards. It is comprised of national standards bodies from 159
countries that promote high quality standards for all company processes. To
meet ISO 9000 certification requirements for Quality Management Systems,
companies must establish a well-tuned system of interacting processes that
ensures consistent quality of the company’s products; their capacity to
optimally meet customer requirements; and their fulfillment of all applicable
regulatory requirements.

    For more information, please contact:

    Shenzhen Beike Biotechnology Company, Ltd.
     T. Gutmann
     Shenzhen Hi-Tech Industrial Park
     Tel:   +86-755-8630-9200
     Email: info@beikebiotech.com
     Web:   http://www.beikebiotech.com

SOURCE Beike Biotechnology Company Limited